Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,100
Closed -$293K 3960
2021
Q4
$293K Sell
1,100
-5,800
-84% -$1.68M ﹤0.01% 3659
2021
Q3
$1.96M Buy
6,900
+4,900
+245% +$1.4M ﹤0.01% 2012
2021
Q2
$549K Buy
+2,000
New +$544K ﹤0.01% 3011
2021
Q1
Sell
-2,400
Closed -$614K 4170
2020
Q4
$614K Sell
2,400
-500
-17% -$124K ﹤0.01% 2354
2020
Q3
$686K Sell
2,900
-700
-19% -$147K ﹤0.01% 2013
2020
Q2
$699K Buy
3,600
+400
+13% +$76.5K ﹤0.01% 1762
2020
Q1
$530K Buy
+3,200
New +$585K ﹤0.01% 1886

Other funds holding PODD

John Overdeck's PODD Position: Q2 2026 in Review

John Overdeck increased its Insulet (PODD) stake by 150% in Q2 2026, buying an estimated $190M and bringing the position to 1,903,734 shares worth $290M. The position accounts for 0.21% of the portfolio, ranked #98.

John Overdeck first reported a position in PODD in Q2 2013 and has held it in 32 quarters since. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • John Overdeck held 1,903,734 shares of Insulet worth $290M as of Q2 2026.
  • John Overdeck bought 1,141,385 Insulet shares in Q2 2026, an estimated $190M.
  • Insulet made up 0.21% of John Overdeck's portfolio in Q2 2026, its #98 holding.
  • John Overdeck first reported a position in Insulet in Q2 2013 and has held it in 32 quarters since.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.